tiprankstipranks
Turn Therapeutics Inc (TTRX)
NASDAQ:TTRX
US Market
TTRX
Turn Therapeutics Inc
RESEARCH TOOLSreports

Turn Therapeutics Inc (TTRX) Stock News & Sentiment

Compare
20 Followers
Turn Therapeutics Secures Growth Capital to Advance Dermatology
Premium
Company Announcements
Turn Therapeutics Secures Growth Capital to Advance Dermatology
5d ago
8K
TTRX
Turn Therapeutics Appoints Robert Redfield as Senior Advisor
Premium
Company Announcements
Turn Therapeutics Appoints Robert Redfield as Senior Advisor
1M ago
8K
TTRX
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
Premium
Company Announcements
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
2M ago
8K
TTRX
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
Premium
Company Announcements
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
2M ago
TTRX
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
Premium
Ratings
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
3M ago
TTRX
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
Premium
Company Announcements
Turn Therapeutics Issues Corporate, Pipeline and Financial Updates
3M ago
8K
TTRX
Turn Therapeutics appoints veteran executive to board
Premium
Company Announcements
Turn Therapeutics appoints veteran executive to board
3M ago
8K
TTRX
More TTRX News >

TTRX News on the Web

Turn Therapeutics Secures Growth Capital to Advance Dermatology
TipRanks News
Neutral
Turn Therapeutics secures up to $25M in financing
TipRanks News
Bullish
Turn Therapeutics Appoints Robert Redfield as Senior Advisor
TipRanks News
Neutral
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
TipRanks News
Neutral
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
TipRanks News
Bullish
Why Turn Therapeutics Inc.’s (TTRX) Stock Is Down 5.15%
AAII
Neutral
Why Turn Therapeutics Inc.’s (TTRX) Stock Is Up 9.63%
AAII
Neutral
Speculative Buy on Turn Therapeutics: Proprietary Platform, Capital-Efficient Growth, and 2026 Milestones as Key Upside Catalysts
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
TTRX
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TTRX’s Media Buzz Sentiment?
2 articles about TTRX were published this week. In an average week, 1 articles are published.
    What is TTRX’s weekly average amount of articles?
    In an average week, 1 articles about TTRX are published.
      What is TTRX’s News Sentiment?
      100% of articles about TTRX were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        PYXSPyxis Oncology
        WXIBFWuxi Biologics (Cayman)
        KODKodiak Sciences
        SHTDYSinopharm Group Co
        GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
        Showing the stocks with the most bullish news sentiment over the past week